Synergistic antidyskinetic effects of topiramate and amantadine in animal models of Parkinson's disease (Q85002422)

From Wikidata

Jump to navigation Jump to search

scientific article published on September 23, 2011

edit

Language	Label	Description	Also known as
English	Synergistic antidyskinetic effects of topiramate and amantadine in animal models of Parkinson's disease	scientific article published on September 23, 2011

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21953539

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21953539%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 February 2020

title

Synergistic antidyskinetic effects of topiramate and amantadine in animal models of Parkinson's disease (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21953539

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21953539%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 February 2020

main subject

Parkinson's disease

1 reference

based on heuristic

inferred from title

author

Christopher Kobylecki

series ordinal

1

object named as

Christopher Kobylecki

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21953539

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21953539

retrieved

13 December 2024

author name string

Paula Ravenscroft

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21953539

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21953539%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 February 2020

Michael P. Hill

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21953539

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21953539

retrieved

13 December 2024

Alan R. Crossman

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21953539

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21953539

retrieved

13 December 2024

language of work or name

English

1 reference

stated in

National Center for Biotechnology Information

PubMed publication ID

21953539

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21953539

retrieved

13 December 2024

publication date

23 September 2011

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21953539

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21953539%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 February 2020

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmds.23867

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.23867/fullpdf

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

published in

Movement Disorders

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21953539

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21953539%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 February 2020

volume

26

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21953539

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21953539%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 February 2020

issue

13

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21953539

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21953539%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 February 2020

page(s)

2354-2363

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21953539

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21953539%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 February 2020

cites work

Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature

series ordinal

1

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Impact of the motor complications of Parkinson's disease on the quality of life

series ordinal

2

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism

series ordinal

3

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia

series ordinal

4

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Molecular mechanisms of L-DOPA-induced dyskinesia

series ordinal

5

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys

series ordinal

6

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model

series ordinal

7

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Levetiracetam potentiates the antidyskinetic action of amantadine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease

series ordinal

8

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

series ordinal

9

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Amantadine for levodopa-induced dyskinesias: a 1-year follow-up study

series ordinal

10

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Long-term antidyskinetic efficacy of amantadine in Parkinson's disease

series ordinal

11

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Amantadine for dyskinesia in Parkinson's disease

series ordinal

12

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment

series ordinal

13

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease

series ordinal

14

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys

series ordinal

15

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Calcium-permeable AMPA receptors are involved in the induction and expression of l-DOPA-induced dyskinesia in Parkinson's disease

series ordinal

16

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons

series ordinal

17

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Topiramate reduces levodopa-induced dyskinesia in the MPTP-lesioned marmoset model of Parkinson's disease.

series ordinal

18

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate

series ordinal

20

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD.

series ordinal

21

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

The nature of the arrestin x receptor complex determines the ultimate fate of the internalized receptor

series ordinal

22

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system.

series ordinal

23

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease

series ordinal

24

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease

series ordinal

25

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function

series ordinal

26

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease.

series ordinal

28

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

An automated rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of parkinsonism

series ordinal

29

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Drug-free evaluation of rat models of parkinsonism and nigral grafts using a new automated rotarod test

series ordinal

30

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan.

series ordinal

31

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease

series ordinal

32

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Topiramate: preclinical evaluation of structurally novel anticonvulsant.

series ordinal

33

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

In vivo microdialysis and liquid chromatography/thermospray mass spectrometry of the novel anticonvulsant 2,3:4,5-bis-o-(1-methylethylidene)-β-D-fructopyranose sulfamate (topiramate) in rat brain fluid

series ordinal

35

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: effects on motor behavior and striatal nuclear signaling

series ordinal

36

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

The new antiepileptic drugs: scientific review

series ordinal

37

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Motor performance and behavior of immature rats are not compromised by a high dose of topiramate.

series ordinal

38

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Beneficial effects of amantadine on L-dopa-induced dyskinesias in Parkinson's disease

series ordinal

39

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study

series ordinal

40

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Design of antagonists for NMDA and AMPA receptors

series ordinal

41

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Effect of nondopaminergic drugs on L-dopa-induced dyskinesias in MPTP-treated monkeys.

series ordinal

42

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on L-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian rat.

series ordinal

43

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Sigma ligands, but not N-methyl-D-aspartate antagonists, reduce levodopa-induced dyskinesias

series ordinal

44

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies: keys to success and roads to failure

series ordinal

45

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Modulation of AMPA receptors in cultured cortical neurons induced by the antiepileptic drug levetiracetam

series ordinal

46

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Quantitation of acetazolamide in rat plasma, brain tissue and cerebrospinal fluid by high-performance liquid chromatography

series ordinal

47

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Subunit selectivity of topiramate modulation of heteromeric GABA(A) receptors.

series ordinal

48

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Topiramate reduces abnormally high extracellular levels of glutamate and aspartate in the hippocampus of spontaneously epileptic rats (SER)

series ordinal

50

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Chronic L-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease

series ordinal

51

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate

series ordinal

52

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons

series ordinal

53

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Topiramate modulation of kainate-induced calcium currents is inversely related to channel phosphorylation level.

series ordinal

54

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Topiramate reduces AMPA-induced Ca(2+) transients and inhibits GluR1 subunit phosphorylation in astrocytes from primary cultures

series ordinal

55

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Changes in subcellular distribution and phosphorylation of GluR1 in lesioned striatum of 6-hydroxydopamine-lesioned and l-dopa-treated rats

series ordinal

56

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia

series ordinal

57

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity

series ordinal

58

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Early alterations of AMPA receptors mediate synaptic potentiation induced by neonatal seizures

series ordinal

59

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Dopamine D1 and D2 receptor contributions to L-DOPA-induced dyskinesia in the dopamine-depleted rat.

series ordinal

60

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Coexpression of striatal dopamine receptor subtypes and excitatory amino acid subunits

series ordinal

61

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Differential expression of NMDA and AMPA receptor subunits in DARPP-32-containing neurons of the cerebral cortex, hippocampus and neostriatum of rats

series ordinal

62

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Synaptic recruitment of AMPA glutamate receptor subunits in levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate.

series ordinal

63

1 reference

stated in

Crossref

DOI

10.1002/MDS.23867

reference URL

https://api.crossref.org/works/10.1002/MDS.23867

retrieved

13 December 2024

Identifiers

DOI

10.1002/MDS.23867

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21953539

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21953539%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 February 2020

PubMed publication ID

21953539

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21953539

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21953539%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 February 2020

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85002422&oldid=2286742538"